000 | 02003 a2200601 4500 | ||
---|---|---|---|
005 | 20250515063509.0 | ||
264 | 0 | _c20070521 | |
008 | 200705s 0 0 eng d | ||
022 | _a0003-9942 | ||
024 | 7 |
_a10.1001/archneur.64.4.558 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRibaï, Pascale | |
245 | 0 | 0 |
_aNeurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up. _h[electronic resource] |
260 |
_bArchives of neurology _cApr 2007 |
||
300 |
_a558-64 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
650 | 0 | 4 |
_aBenzoquinones _xtherapeutic use |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aEchocardiography |
650 | 0 | 4 | _aElectrocardiography, Ambulatory |
650 | 0 | 4 |
_aElectrooculography _xmethods |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aFriedreich Ataxia _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIron-Binding Proteins _xgenetics |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeurologic Examination |
650 | 0 | 4 | _aParis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aTrinucleotide Repeat Expansion |
650 | 0 | 4 |
_aUbiquinone _xanalogs & derivatives |
650 | 0 | 4 | _aFrataxin |
700 | 1 | _aPousset, Françoise | |
700 | 1 | _aTanguy, Marie-Laure | |
700 | 1 | _aRivaud-Pechoux, Sophie | |
700 | 1 | _aLe Ber, Isabelle | |
700 | 1 | _aGasparini, Franchesca | |
700 | 1 | _aCharles, Perrine | |
700 | 1 | _aBéraud, Anne-Sophie | |
700 | 1 | _aSchmitt, Michele | |
700 | 1 | _aKoenig, Michel | |
700 | 1 | _aMallet, Alain | |
700 | 1 | _aBrice, Alexis | |
700 | 1 | _aDürr, Alexandra | |
773 | 0 |
_tArchives of neurology _gvol. 64 _gno. 4 _gp. 558-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/archneur.64.4.558 _zAvailable from publisher's website |
999 |
_c16971405 _d16971405 |